While we observed partial neutralization of SARS-CoV-2 infection using a neutralizing anti-ACE2 antibody, we were unable to fully inhibit infection indicating that the mechanism of viral entry to the cells of the CNS may involve a different pathway to that reported for nasopharyngeal epithelium and other sites of infection [14]. The gene discussed is ACE2; the disease is infection.